Tech Company Financing Transactions

Apnimed Funding Round

Sectoral Asset Management, Alpha Wave Ventures and Morningside Group participated in a $62.5 million Series C capital raise for Apnimed. The financing round closed on 5/4/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

20 Holyoke St.
Cambridge, MA 02138
USA

Phone

(617) 500-8880

Website

www.apnimed.com

Email Address

Not Recorded

Overview

Apnimed was built upon a simple idea -- patients with Obstructive Sleep Apnea (OSA) need a safe and effective medication that addresses the underlying biology of the disease. OSA is a serious disorder in which the upper airway partly or completely closes during sleep.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Larry Miller

        

Chief Financial Officer

Michael Rogers

        

Chief Medical Officer

Ron Farkas

        

Chief Operating Officer

Dennis Molnar

        

Chief Scientific Officer

Luigi Montemurro

        

VP - Bus. Development

Barry Wohl

        

Browse more venture capital transactions:

Prev: 5/4/2022: Getlife venture capital transaction
Next: 5/4/2022: Allocate venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary